Off-label use of intravitreal bevacizumab (Avastin) for salvage treatment in progressive threshold retinopathy of prematurity

Geeta A. Lalwani, Audina M. Berrocal, Timothy G. Murray, Maria M Buch, Scott Cardone, Ditte Hess, Rose A. Johnson, Carmen A. Puliafito

Research output: Contribution to journalArticlepeer-review

114 Scopus citations

Fingerprint

Dive into the research topics of 'Off-label use of intravitreal bevacizumab (Avastin) for salvage treatment in progressive threshold retinopathy of prematurity'. Together they form a unique fingerprint.

Medicine & Life Sciences